Français
ItalianoBond AbbVie 4.75% ( USU0029QBG02 ) in USD
| Issuer | AbbVie | ||||||||||||||
| Market price |  126.763 % ⇌ |
||||||||||||||
| Country |  United States
|
||||||||||||||
| ISIN code |
 USU0029QBG02 ( in USD )
|
||||||||||||||
| Interest rate | 4.75% per year ( payment 2 times a year) | ||||||||||||||
| Maturity | 03/15/2045 | ||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||
| Total amount | 827 096 000 USD | ||||||||||||||
| Cusip | U0029QBG0 | ||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||
| Next Coupon | 03/15/2027 ( In 127 days ) | ||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code USU0029QBG02, pays a coupon of 4.75% per year. The coupons are paid 2 times per year and the Bond maturity is 03/15/2045 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code USU0029QBG02, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||
| |||||||||||||||